Met Life Investment Management, LLC Evelo Biosciences, Inc. Transaction History

Met Life Investment Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$6.79 - $13.9 $82,518 - $168,926	-12,153 Closed	0 $0
Q2 2021 May 17, 2024	BUY	$9.43 - $16.6 $114,602 - $201,739	12,153 New	12,153 $166,000
Q2 2021 Jun 21, 2023	BUY	$9.43 - $16.6 $114,602 - $201,739	12,153 New	12,153 $166,000
Q2 2021 Mar 22, 2023	BUY	$9.43 - $16.6 $114,602 - $201,739	12,153 New	12,153 $166,000
Q2 2021 Aug 16, 2021	BUY	$9.43 - $16.6 $114,602 - $201,739	12,153 New	12,153 $167,000

Ticker EVLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,994,000
Description
Evelo Biosciences, Inc., a biotechnology company, discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. It is developing EDP1815, a whole-microbe candidate for the treatment of inflammatory diseases; and is in Phase 2 clinical trial for the treatment of psoriasis and atopic dermatitis, as well as for the hy...

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Met Life Investment Management, LLC with notifications on news.